Jingye Zhou, Eccogene CEONovember 9, 2023 03:54 AM ESTUpdated 06:32 AM DealsR&DAstraZeneca puts down $185M upfront for PhI oral GLP-1 as it shoots for next-gen winAmber TongSenior EditorAstraZeneca has recruited a new star to its budding GLP-1 show, picking up an early-stage oral candidate from China’s Eccogene in a deal featuring $185 million upfront. While...